Omnipaque 350mg/100ml (Iohexol Vials) 350mg/100ml

Omnipaque 350mg/100ml is a non-ionic, iodinated contrast agent in vial form, used for radiographic imaging procedures. This contrast medium enhances visibility of internal structures during CT scans and other imaging techniques. Store at ambient temperature to maintain stability.

Strength

350mg/100ml

Pack Size

Storage

Ambient

Manufacturer / TM Owner

GE Healthcare Shanghai Co Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Iohexol, the active ingredient in Omnipaque 350mg/100ml, is used to improve the clarity of X-ray images during medical imaging procedures. It is commonly used for what is iohexol used for in CT scans, angiograms, and other diagnostic tests. The 350mg/100ml concentration provides a balance of contrast and safety for adult imaging needs.

Side Effects

After administration, iohexol enhances the visibility of blood vessels, organs, and tissues on X-ray images. Patients may experience a warm sensation or metallic taste temporarily. Mild discomfort at the injection site is also common but typically resolves quickly.

Precautions & Warnings

Omnipaque 350mg/100ml should be handled by healthcare professionals trained in contrast media use. Ensure the patient is well-hydrated before administration to reduce the risk of kidney-related effects. Discard any unused portion of the vial after opening to maintain sterility.

Avoid Interactions

Concomitant use with certain medications, such as metformin or nephrotoxic drugs, may require additional monitoring. Alcohol consumption may increase the risk of adverse effects. Always inform your healthcare provider about all medications and conditions before receiving iohexol.

References

Frequently Asked Questions

Iohexol is used to enhance the visibility of internal structures during radiographic procedures like CT scans and angiograms.

Store at ambient temperature, away from direct sunlight and moisture, to maintain its stability and effectiveness.

Consult your healthcare provider before use, as contrast agents may require additional precautions in patients with kidney conditions.

Common effects include a warm sensation, metallic taste, or mild discomfort at the injection site.

Alcohol may increase the risk of adverse effects; it is advisable to avoid it during and shortly after the procedure.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.